GDC-0927
Modify Date: 2024-01-14 18:47:39
GDC-0927 structure
|
Common Name | GDC-0927 | ||
|---|---|---|---|---|
| CAS Number | 1642297-01-5 | Molecular Weight | 461.52 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C28H28FNO4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of GDC-0927GDC-0927 (SRN-927) is a novel, potent, non-steroidal, orally bioavailable, selective estrogen receptor antagonist. |
| Name | GDC-0927 |
|---|
| Description | GDC-0927 (SRN-927) is a novel, potent, non-steroidal, orally bioavailable, selective estrogen receptor antagonist. |
|---|---|
| Related Catalog | |
| Target |
Estrogen receptor[1] |
| In Vivo | GDC-0927 is a novel, potent, non-steroidal, orally bioavailable, selective ER antagonist/ER degrader (SERD) that induces tumor regression in estrogen receptor (ER)+breast cancer (BC) patient-derived xenograft models[1]. |
| References |
| Molecular Formula | C28H28FNO4 |
|---|---|
| Molecular Weight | 461.52 |
| Storage condition | 2-8℃ |